Fig. 19From: Evaluation of the anticancer potential of CD44 targeted vincristine nanoformulation in prostate cancer xenograft model: a multi-dynamic approach for advanced pharmacokinetic evaluationCOX-II immunohistochemistry results for control groups. Control group (brain: A1, heart: A2, kidney, A3, liver: A4, lung: A5) n = 10, mean + SD, p ≤ 0.05. Images were taken at 10× and 40×Back to article page